NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 60 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,938,000 | -1.0% | 3,600,000 | 0.0% | 0.12% | -8.7% |
| Q4 2020 | $4,986,000 | -21.3% | 3,600,000 | -21.7% | 0.13% | -32.4% |
| Q3 2020 | $6,339,000 | -19.8% | 4,600,000 | -3.2% | 0.19% | -25.1% |
| Q2 2020 | $7,901,000 | +42.1% | 4,750,000 | +9.2% | 0.25% | +27.4% |
| Q1 2020 | $5,560,000 | +54.2% | 4,350,000 | +85.1% | 0.20% | +93.1% |
| Q4 2019 | $3,605,000 | +25.0% | 2,350,000 | +11.9% | 0.10% | +15.9% |
| Q3 2019 | $2,884,000 | +36.6% | 2,100,000 | +31.2% | 0.09% | +35.4% |
| Q2 2019 | $2,112,000 | -2.5% | 1,600,000 | 0.0% | 0.06% | -7.1% |
| Q1 2019 | $2,166,000 | +65.0% | 1,600,000 | +45.5% | 0.07% | +45.8% |
| Q4 2018 | $1,313,000 | -30.1% | 1,100,000 | 0.0% | 0.05% | -7.7% |
| Q3 2018 | $1,879,000 | +17.8% | 1,100,000 | 0.0% | 0.05% | +13.0% |
| Q2 2018 | $1,595,000 | – | 1,100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |